ASIX · AdvanSix Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 7, 2026TL;DR. AdvanSix's Q2 results showed 3% sales growth to $421 million, but adjusted EPS fell 85% to $0.19 and adjusted EBITDA dropped 43% to $31.9 million on weaker plant nutrients volumes; management guided to second-half sequential improvement supported by lower CapEx, a $0.16 dividend, and progress on the DEF project and USDA FIELDS grant application for ammonia capacity expansion.
- + CapEx guidance of $75–$95 million in 2026, down from $116 million in 2025, supports second-half free cash flow improvement.
- + Full-year 2026 ammonia sales volume expected up 30% versus the prior record year 2025.
- + Targeting approximately $10 million savings exiting 2026 from the multi-year non-manpower fixed cost reduction program.
- − Q2 adjusted EPS of $0.19 was down 85% year-over-year and adjusted EBITDA fell 43% to $31.9 million on lower plant nutrients volumes.
- − Plant Nutrients sales fell 16% year-over-year to $131.4 million as weaker farmer economics reduced in-season fertilizer purchases.
- − Q2 2026 plant turnaround pre-tax impact of ~$10 million and full-year turnaround impact now expected at ~$17 million vs. previously expected to be lower.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA (non-GAAP) non-GAAP | $31.89M | Three Months Ended June 30, 2026 filing | — |
| Adjusted EBITDA Margin non-GAAP | 4.4% | Six Months Ended June 30 | — |
| Adjusted EPS - Basic non-GAAP | -$0.3 | Six Months Ended June 30 | — |
| Adjusted EPS - Diluted non-GAAP | -$0.3 | Six Months Ended June 30 | — |
| Adjusted Net income (loss) (non-GAAP) non-GAAP | $5.2M | Three Months Ended June 30, 2026 filing | — |
| Total approximate dividend amount | $4.3M | three months ended June 30, 2026 filing | — |
| Total dividend per share | $0.16 | three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASIX
this stock
AdvanSix Inc.
|
$429.86M | -7.6% | +45.5% | — | 1.9% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$67.96B | +17.1% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$20.65B | +18.0% | -7.0% | — | 4.9% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$15.19B | +14.1% | — | — | 0.0% |
|
CE
Celanese Corp
|
$4.93B | +4.5% | -7.1% | — | 6.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASIX | +1.5% | -9.3% | -33.3% | +0.4% | -7.6% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | +1.9% | -9.2% | -45.7% | +0.2% | -19.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.